Central Nervous System Disorders Stocks List

Recent Signals

Date Stock Signal Type
2021-06-23 ACAD Fell Below 20 DMA Bearish
2021-06-23 ACAD Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-06-23 ACOR Doji - Bearish? Reversal
2021-06-23 ACOR Upper Bollinger Band Walk Strength
2021-06-23 ACOR Calm After Storm Range Contraction
2021-06-23 BEAM NR7 Range Contraction
2021-06-23 BEAM Pocket Pivot Bullish Swing Setup
2021-06-23 BEAM Bollinger Band Squeeze Range Contraction
2021-06-23 BEAM Narrow Range Bar Range Contraction
2021-06-23 DRRX 20 DMA Resistance Bearish
2021-06-23 DRRX Bollinger Band Squeeze Range Contraction
2021-06-23 ENDP Lower Bollinger Band Walk Weakness
2021-06-23 HUGE Stochastic Buy Signal Bullish
2021-06-23 HUGE NR7 Range Contraction
2021-06-23 IRWD New 52 Week High Strength
2021-06-23 KRTX Stochastic Sell Signal Bearish
2021-06-23 NRXP Narrow Range Bar Range Contraction
2021-06-23 NRXP Stochastic Buy Signal Bullish
2021-06-23 NRXP NR7 Range Contraction
2021-06-23 PASG 20 DMA Resistance Bearish
2021-06-23 PRAX Spinning Top Other
2021-06-23 PRAX NR7 Range Contraction
2021-06-23 PRTC Narrow Range Bar Range Contraction
2021-06-23 SAGE Calm After Storm Range Contraction
2021-06-23 SAGE NR7-2 Range Contraction
2021-06-23 SAGE NR7 Range Contraction
2021-06-23 TRVN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-06-23 TRVN NR7 Range Contraction
2021-06-23 TRVN 20 DMA Resistance Bearish
2021-06-23 VNDA NR7 Range Contraction
2021-06-23 VNDA Cup with Handle Other
2021-06-23 VNDA NR7-2 Range Contraction
2021-06-23 ZGNX Bollinger Band Squeeze Range Contraction
2021-06-23 ZGNX Volume Surge Other
2021-06-23 ZGNX Fell Below 20 DMA Bearish

Central Nervous System Disorders Stocks Recent News

Date Stock Title
Jun 23 ZGNX Zogenix's Current Price Seems Disconnected From A Strong Fintepla Launch
Jun 23 DRRX DURECT Corporation Presents Additional Clinical Data from DUR-928 Phase 1b Trial in NASH and Phase 1 Trial in Hepatic Impairment at the International Liver Conference 2021 (EASL)
Jun 23 PRTC PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
Jun 23 KRTX Karuna Therapeutics reports KarXT results from Phase 1b study in healthy elderly volunteers
Jun 23 KRTX Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
Jun 23 AXSM Ditch Dogecoin: These 3 Stocks Could Double Your Money
Jun 22 SAGE CVS and Rite Aid get price target cuts, Sage target trimmed on depression drug data, and more in analyst action
Jun 22 MNOV MNOV: Positive Results for MN-166 in Phase 2 AUD Trial…
Jun 22 VNDA Oil Up, Brent Tops $75 Mark as Signs of Rapidly Tightening Market Emerge
Jun 21 MNOV SAFM, WISH, MVIS and MNOV among after-hours movers
Jun 21 ACAD SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 21, 2021 - ACAD
Jun 21 ACAD Today - Final Deadline for Investors With Losses Exceeding $100K to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC
Jun 21 TRVN All You Need to Know About Trevena (TRVN) Rating Upgrade to Buy
Jun 21 MNOV Virpax Pharmaceuticals, Anavex Life Sciences leads healthcare gainers; Aptevo Therapeutics, Intec Pharma among major losers
Jun 21 SAGE How Sage Therapeutics Stock Could Make a Comeback
Jun 21 ACAD Lawsuits Filed Against ACAD, EBS and WISH - Jakubowitz Law Pursues Shareholders Claims
Jun 21 ZGNX Zogenix to Participate in Two Upcoming Investor Conferences
Jun 21 MNOV MediciNov's MN-166 Reduces Odds Of Heavy Drinking by 45% After 14 Days Of Treatment
Jun 21 MNOV MediciNova stock climbs 31% on positive MN-166 data in mid-stage alcohol use disorder study
Jun 21 MNOV MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Nature’s Translational Psychiatry Journal